1 / 29

Reassessing the Role of Somatostatin Analogs in the Treatment of NETs

Reassessing the Role of Somatostatin Analogs in the Treatment of NETs. Activity Goals. Categories of NETs. Carcinoid Tumors. Symptoms From Hormone Production. The PROMID Study Design. PROMID Study Results. CLARINET Study. CLARINET Study: Results. Phase 3: Pasireotide vs Octreotide.

reya
Download Presentation

Reassessing the Role of Somatostatin Analogs in the Treatment of NETs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Reassessing the Role of Somatostatin Analogs in the Treatment of NETs

  2. Activity Goals

  3. Categories of NETs

  4. Carcinoid Tumors

  5. Symptoms From Hormone Production

  6. The PROMID Study Design

  7. PROMID Study Results

  8. CLARINET Study

  9. CLARINET Study: Results

  10. Phase 3: Pasireotide vs Octreotide

  11. Phase 3 Study: Results

  12. Curve to Show Difference in Disease Control?

  13. ELECT Study

  14. Temozolomide-based Regimens

  15. CAPTEM

  16. PFS and OS With CAPTEM

  17. Conclusions

  18. Streptozocin-based Regimens

  19. Abbreviations

  20. Abbreviations (cont)

  21. References

  22. References (cont)

  23. References (cont)

  24. References (cont)

  25. References (cont)

  26. References (cont)

  27. References (cont)

More Related